2266 related articles for article (PubMed ID: 16847081)
1. Pathogenesis of Helicobacter pylori infection.
Kusters JG; van Vliet AH; Kuipers EJ
Clin Microbiol Rev; 2006 Jul; 19(3):449-90. PubMed ID: 16847081
[TBL] [Abstract][Full Text] [Related]
2. [Inflammation as a basis for Helicobacter pylori-associated diseases].
Kononov AV
Arkh Patol; 2006; 68(5):3-10. PubMed ID: 17144521
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-induced gastric inflammation and gastric cancer.
Wang F; Meng W; Wang B; Qiao L
Cancer Lett; 2014 Apr; 345(2):196-202. PubMed ID: 23981572
[TBL] [Abstract][Full Text] [Related]
4. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
Chen XJ; Yan J; Shen YF
Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori virulence markers in gastroduodenal disorders. Detection of cytotoxin-associated gene A and vacuolating cytotoxin-associated gene A genes in Saudi patients.
Al-Khattaf AS
Saudi Med J; 2012 Jul; 33(7):716-21. PubMed ID: 22821304
[TBL] [Abstract][Full Text] [Related]
6. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
[TBL] [Abstract][Full Text] [Related]
7. What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases.
da Costa DM; Pereira Edos S; Rabenhorst SH
World J Gastroenterol; 2015 Oct; 21(37):10563-72. PubMed ID: 26457016
[TBL] [Abstract][Full Text] [Related]
8. [Immunoproteomics of Helicobacter pylori--strategy for improvement of diagnostic tests and vaccine development].
Roszczenko P; Jagusztyn-Krynicka EK
Postepy Biochem; 2006; 52(4):424-34. PubMed ID: 17536512
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity island-dependent effects of Helicobacter pylori on intracellular signal transduction in epithelial cells.
Naumann M
Int J Med Microbiol; 2005 Sep; 295(5):335-41. PubMed ID: 16173500
[TBL] [Abstract][Full Text] [Related]
10. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
[TBL] [Abstract][Full Text] [Related]
11. [Molecular detection of Helicobacter pylori vacA and cagA genes in gastric tissue specimens of patients with peptic ulcer disease and non-ulcer dyspepsia].
Karaman M; Abacıoğlu H; Topalak OS; Simşek I
Mikrobiyol Bul; 2011 Jan; 45(1):11-20. PubMed ID: 21341154
[TBL] [Abstract][Full Text] [Related]
12. The role of CagA status in gastric and extragastric complications of Helicobacter pylori.
Perez-Perez GI; Peek RM; Legath AJ; Heine PR; Graff LB
J Physiol Pharmacol; 1999 Dec; 50(5):833-45. PubMed ID: 10695563
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori virulence factors--one part of a big picture.
Höcker M; Hohenberger P
Lancet; 2003 Oct; 362(9391):1231-3. PubMed ID: 14568748
[TBL] [Abstract][Full Text] [Related]
14. The role of the putative virulence markers (cagA and vacA ) of Helicobacter pylori in peptic ulcer disease.
Salih BA
Saudi Med J; 2004 Jul; 25(7):830-6. PubMed ID: 15235683
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Helicobacter pylori infection.
Maeda S; Mentis AF
Helicobacter; 2007 Oct; 12 Suppl 1():10-4. PubMed ID: 17727454
[TBL] [Abstract][Full Text] [Related]
16. Immunology of Helicobacter pylori infection.
Velin D; Michetti P
Digestion; 2006; 73(2-3):116-23. PubMed ID: 16788292
[TBL] [Abstract][Full Text] [Related]
17. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.
Mattar R; dos Santos AF; Eisig JN; Rodrigues TN; Silva FM; Lupinacci RM; Iriya K; Carrilho FJ
Helicobacter; 2005 Dec; 10(6):601-8. PubMed ID: 16302986
[TBL] [Abstract][Full Text] [Related]
18. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of Helicobacter pylori infection.
Radosz-Komoniewska H; Bek T; Jóźwiak J; Martirosian G
Clin Microbiol Infect; 2005 Aug; 11(8):602-10. PubMed ID: 16008611
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Helicobacter pylori infection.
Cid TP; Fernández MC; Benito Martínez S; Jones NL
Helicobacter; 2013 Sep; 18 Suppl 1():12-7. PubMed ID: 24011239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
